Forum Markets Incorporated (FRMM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Special Meeting scheduled for October 7, 2025, to address key governance and capital structure proposals.
Board recommends voting in favor of all eight proposals, including director election, incentive plans, and amendments to the certificate of incorporation.
Proposals aim to enhance equity compensation, increase authorized shares, and streamline governance documents.
Voting matters and shareholder proposals
Election of Jason New as Class II director to serve until 2026.
Approval of the 2025 Omnibus Incentive Plan, 2025 Supplemental Option Incentive Plan, and 2025 Second Supplemental Option Incentive Plan.
Approval to remove the Nasdaq 20% cap for convertible notes, allowing potential issuance of shares exceeding 20% of outstanding stock.
Amendment to increase authorized common stock from 1 billion to 5 billion shares.
Amendments to remove obsolete provisions and clarify the certificate of incorporation.
Approval to adjourn the meeting if additional proxies are needed.
Board of directors and corporate governance
Board led by Executive Chairman/CEO McAndrew Rudisill, with Ryan Smith as Lead Independent Director.
Three standing committees: Audit, Compensation, and Nominating & Corporate Governance, all composed of independent directors.
Board and committee members have significant experience in finance, investment, and operations.
Board structure includes staggered two-year terms for directors.
Latest events from Forum Markets Incorporated
- Tokenizing real-world assets on Ethereum unlocks high-yield, compliant investment opportunities.FRMM
Investor presentation20 Mar 2026 - Tokenizing real-world assets for yield, with rapid expansion and institutional focus.FRMM
Sidoti March Small-Cap Virtual Conference18 Mar 2026 - Tokenizing real-world assets for high-yield, compliant DeFi access and institutional adoption.FRMM
Investor presentation23 Jan 2026 - Registers 2.7M shares for resale amid DeFi expansion, ETH exposure, and high financial risk.FRMM
Registration Filing18 Dec 2025 - Registering 752,873 shares for resale as company pivots from biotech to blockchain iGaming.FRMM
Registration Filing16 Dec 2025 - Transitioning to blockchain iGaming, raising up to $500M for growth and strategic initiatives.FRMM
Registration Filing16 Dec 2025 - Stockholders will vote on director elections, equity plan expansion, major stock issuances, and auditor ratification.FRMM
Proxy Filing2 Dec 2025 - Shareholders to vote on director election, equity plans, and major capital structure amendments.FRMM
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, incentive plan expansion, major share issuances, and auditor ratification.FRMM
Proxy Filing2 Dec 2025